|

BMS-986253 Clinical Trials

1 actively recruiting trial

▼ -1 trial since August 2026

Also known as: Anti-IL-8, Anti-IL8

Pipeline

Phase 2: 1

Top Sponsors

  • The Netherlands Cancer Institute1

Indications

Other1 trial

Neoadjuvant Immune Checkpoint Inhibition and Novel IO Combinations in Early-stage Colon Cancer
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.